ORIGINAL RESEARCH article
Front. Immunol.
Sec. Viral Immunology
Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1566690
Multiomics analysis unveils key biomarkers during dynamic progress of IAV infection in mice
Provisionally accepted- 1School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China
- 2School of Pharmacy, Chengdu University, Chengdu, Sichuan Province, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Influenza infection poses a significant threat to public health, and understanding the dynamic biomarkers that influence disease progression is crucial for effective intervention. We conducted a comprehensive evaluation of the physiological and pathological parameters in Balb/c mice infected with H1N1 influenza over a 14-day period, highlighting the critical importance of intervention within the first 6 days post-infection to prevent severe disease. We first employed the DIABLO multi-omics integration method to analyze the dynamic changes in the lung transcriptome, metabolome, and serum metabolome of influenza-infected mice from the mild to severe stages, identifying several novel biomarkers associated with disease progression, including Ccl8, Pdcd1, Gzmk, kynurenine, L-glutamine, and adipoyl-carnitine. Finally, we developed a serum-based influenza disease progression scoring system, which serves as a valuable tool for the early diagnosis and prognosis of severe influenza. This study provides new insights into the molecular mechanisms underlying influenza progression and identifies potential targets for therapeutic intervention.
Keywords: Influenza A virus, multiomics integration, Disease severity prediction, L-glutamine, biomarker
Received: 25 Jan 2025; Accepted: 29 Apr 2025.
Copyright: © 2025 Lei, Xu, Zhang, Zhang, Luo, Liu, Zhang, Yang, Wen, Wang and Xu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Ping Wang, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China
Shijun Xu, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.